| Literature DB >> 9538302 |
C M Newman1, A Price, D W Davies, T A Gray, A P Weetman.
Abstract
Amiodarone induces predictable changes in thyroid function tests that are largely explicable in terms of the physiological effects of iodide excess and inhibition of deiodinase activity. Clinically relevant thyroid dysfunction is not uncommon during amiodarone therapy, and requires careful diagnosis and treatment. The diagnosis and management of thyrotoxicosis is probably best supervised by a specialist endocrinologist. Control of hypothyroidism can generally be achieved simply by the addition of T4 to the therapeutic regimen, ideally after an initial assessment by an endocrinologist. The frequency with which amiodarone causes thyroid and other complications serves to emphasize the need for rational prescribing and long-term cardiological follow up.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9538302 PMCID: PMC1728611 DOI: 10.1136/hrt.79.2.121
Source DB: PubMed Journal: Heart ISSN: 1355-6037 Impact factor: 5.994